Neurotrophins and neuropathic pain in patients with traumatic brain injury

DOI QR Code

Baik, Jiseok (Department of Anesthesia and Pain Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine)

Wurzelmann M, Romeika J, Sun D. Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury. Neural Regen Res 2017; 12: 7-12. https://doi.org/10.4103/1673-5374.198964
Khan N, Smith MT. Neurotrophins and neuropathic pain: role in pathobiology. Molecules 2015; 20: 10657-88. https://doi.org/10.3390/molecules200610657
Kowianski P, Lietzau G, Czuba E, Waskow M, Steliga A, Morys J. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 2018; 38: 579-93. https://doi.org/10.1007/s10571-017-0510-4
Marcol W, Kotulska K, Larysz-Brysz M, Kowalik JL. BDNF contributes to animal model neuropathic pain after peripheral nerve transection. Neurosurg Rev 2007; 30: 235-43. https://doi.org/10.1007/s10143-007-0085-5
Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Graos MM, et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 2005; 12: 1329-43. https://doi.org/10.1038/sj.cdd.4401662
Korley FK, Diaz-Arrastia R, Wu AH, Yue JK, Manley GT, Sair HI, et al. Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J Neurotrauma 2016; 33: 215-25. https://doi.org/10.1089/neu.2015.3949

Neurotrophins Time Point Intervention after Traumatic Brain Injury: From Zebrafish to Human vol.22, pp.4, 2020, https://doi.org/10.3390/ijms22041585